<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The role of the human fibroblast growth factor receptor (FGFR) gene family in current prenatal diagnosis and management of <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> syndromes and <z:hpo ids='HP_0002652'>skeletal dysplasias</z:hpo> is discussed </plain></SENT>
<SENT sid="1" pm="."><plain>METHOD: We present the antenatal ultrasound findings, diagnosis, and management of 2 cases of <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndrome</z:e> before and after molecular prenatal diagnosis was available </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS AND CONCLUSION: Discovery of mutations in FGFR genes now allows the definitive antenatal diagnosis of <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndrome</z:e>, other <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> syndromes, and <z:hpo ids='HP_0002652'>skeletal dysplasias</z:hpo> </plain></SENT>
</text></document>